Journal info
|
||
Select Journal
Journals
Bratislava Medical Journal Endocrine Regulations General Physiology and Biophysics Neoplasma 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Neoplasma Vol.54, p.16-20, 2007 |
||
Title: New [1,2,4]triazolo[4,3-c]quinazoline enhances cisplatin- and temozolomide-induced growth inhibition and apoptosis in HL-60 cells | ||
Author: L. CIPAK, S. LETASIOVA, A. REPICKY, S. JANTOVA | ||
Abstract: The purpose of this study was to investigate the therapeutic potential of a newly synthesized [1,2,4]triazolo[4,3- c]quinazoline (NTCHMTQ) alone and in combination with two anticancer drugs (cisplatin and temozolomide) against HL- 60 leukemia cell line. The IC50 value of NTCHMTQ toward HL-60 cells was 19.7 μM. No apoptosis and cell cycle changes were observed in cells treated with 5 μM NTCHMTQ alone. Combination of non-toxic concentrations of NTCHMTQ (1 – 5 μM) with cisplatin or temozolomide sensitized HL-60 cells to these two drugs and significantly enhanced their efficacies, that is illustrated by combination indexes, sub-G0 cell fraction, apoptotic DNA fragmentation and caspase-3 activity. The results suggest that combined therapy of non-toxic concentrations of NTCHMTQ with chemotherapeutics may provide synergistic regimen for treatment of leukemia. However, further in vitro and in vivo experimental drug-cell and drug-drug studies are warranted. |
||
Keywords: chemotherapy, modulator, quinazoline, apoptosis, cisplatin, temozolomide | ||
Year: 2007, Volume: 54, Issue: | Page From: 16, Page To: 20 | |
|
download file |
|